Skip to main content

Idexx Laboratories Inc. Value Stock - Dividend - Research Selection

Idexx

ISIN: US45168D1046 , WKN: 888210

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic and health-monitoring products for livestock, poultry, and dairy markets; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


What You Need to Know Ahead of IDEXX Laboratories' Earnings Release

2026-04-21
IDEXX Laboratories is ready to release its fiscal first-quarter earnings next month, and analysts project a double-digit profit growth.

Is It Too Late To Consider IDEXX Laboratories (IDXX) After A 43% One Year Rally?

2026-04-18
If you are wondering whether IDEXX Laboratories at around US$589 per share is still a sensible entry or if you are late to the story, this breakdown will focus squarely on what you are paying for today. The stock has returned 4.7% over the past week and 2.1% over the last month, while year to date it is down 12.1% but up 43.2% over the past year. Recent coverage has highlighted IDEXX Laboratories as a key player in veterinary diagnostics and animal health solutions, which helps explain why...

Citi Just Made Zoetis Its Top Pick With a Buy Rating: Is the Pet Economy Boom the Best Trade of 2026?

2026-04-15
One of Wall Street’s top firms just gave a thumbs-up to Zoetis (NYSE:ZTS) stock. Citi initiated coverage with a Buy rating and a $145 price target, naming it the firm’s top pick in the animal health group. The thesis is straightforward: people treat their animals like family. The initiation is part of a broader sector ... Citi Just Made Zoetis Its Top Pick With a Buy Rating: Is the Pet Economy Boom the Best Trade of 2026?

Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls

2026-04-15
Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls

Citigroup Initiates Coverage On IDEXX Laboratories with Neutral Rating, Announces Price Target of $650

2026-04-15
Citigroup analyst Daniel Grosslight initiates coverage on IDEXX Laboratories (NASDAQ:IDXX) with a Neutral rating and announces Price Target of $650.

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

2026-04-15
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Is it a Prudent Move to Retain IDXX Stock in Your Portfolio Now?

2026-04-14
IDEXX rides on strong diagnostics growth and software momentum, but FX pressure and weak solvency cloud its outlook - should investors hold now?

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

2026-04-14
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?

2026-04-13
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

IDEXX Laboratories Stock Up 39.4% in a Year: What's Driving It?

2026-04-13
IDXX stock surges over the past year, fueled by strong diagnostics growth, innovation traction and expanding global demand in pet healthcare markets.